LG Life Sciences to release new sustained-release formulations of human growth hormone

Published: 2009-04-23 06:56:00

Updated: 2009-04-23 06:56:00

LG Life Sciences (LGLS) is expected to launch its home-grown sustained-release preparation of human growth hormone for treatment of SGA (small for gestational age) in Korea under the trade name Eutropine Plus.

Infants whose weight is the 10th percentile for gestational age are classified as S...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK